gardp.orgGARDP | Global Antibiotic Research and Development Partnership

GARDP Who we are Governance Team Global network Partners Our work What we do Our strategy Agreements Our programmes Serious bacterial infectionssepsis Neonatal sepsis Sexually transmitted infections Discoveryexploratory research Access to antibiotics SECURE Scientific affairsREVIVE News All Press releases Media coverage Statements Events Publications Annual Report Videosstories Get involved Take action Donate to GARDP RFPlicensing opportunities Share your story Learn about antibiotics Work with us PowerOfAntibiotics About GARDP Who we are Governance Team Global network Partners Our work What we do Our strategy Agreements Our programmes Serious bacterial infectionssepsis Neonatal sepsis Sexually transmitted infections Discoveryexploratory research Access to antibiotics SECURE Scientific affairsREVIVE News All Press releases Media coverage Statements Events Publications Annual Report Videosstories Get involved Take action Donate to GARDP RFPlicensing opportunities Share your story Learn about antibiotics Work with us PowerOfAntibiotics AMR Symposium: Partnering to accelerate antibiotic development and access to tackle drug-resistant bacterial infections REGISTER NOW Climate change is a worse health threat than we think READ MORE Achieving a successful outcome to the UN High-Level Meeting on AMR: GARDP's perspective READ POLICY PAPER Tackling the threat of antimicrobial resistance in neonates and children: outcomes from the first WHO-convened Paediatric Drug Optimisation exercise for antibiotics READ MORE THE RACE IS ON Together we can stay ahead of antibiotic resistance TAKE ACTION GARDP Strategy 2024-2028 LEARN MORE The Global Antibiotic ResearchDevelopment Partnership (GARDP) accelerates the development and access of treatments for drug-resistant bacterial infections. Together with public, private and non-profit partners, GARDP works to preserve the power of antibiotics for generations to come. Antibiotic resistance can affect anyone, anywhere Antibiotic resistance occurs when bacteria change over time and no longer respond to treatment. It is already associated with nearly 5 million deaths per year, making it one of the world’s biggest killers . A global crisis of antibiotic resistance Antibiotic resistance has been identified as one of the top 10 global health threats by the World Health Organization. Antibiotic resistance is spreading all over the world as a pandemic of drug-resistant infections. Low- and middle-income countries, and certain population groups like women and children are hit hardest. If left unchecked, antibiotic resistance may make it too risky to carry out routine surgeries and other modern medical interventions. GARDP is acting now to counter drug resistance and save lives Developing new treatments for public health needs GARDP is working to deliver on its5by2025 ” initiative and to expand its portfolio with new treatments for bacterial infections that pose the greatest threat to human health. Access to antibiotics for patients in need around the world GARDP’s agreements with pharmaceutical and biotech companies have the potential to slash delays in access to antibiotics from decades to years. Partnerships to revitalize antibiotic development We engage with all key stakeholders from the get-go to coordinate efforts in the antibiotic pipeline to develop an ecosystem of antibiotic RD and access . Addressing urgent threats to public health Neonatal sepsis 1 in 5 deaths caused by drug-resistant infections occur in children under the age of five, and up to 3 million newborns get serious infections that lead to sepsis every year. Read More Serious bacterial infectionssepsis Serious bacterial infections are among the major causes of death for people in hospitals and other healthcare settings. Read More Sexually transmitted infections Gonorrhoea affects 82 million people each year, and disproportionately harms women. Resistant strains are spreading around the world. Read More Discoveryexploratory research Growing drug resistance is outpacing the development of antibiotics for the most difficult-to-treat infections. Producing such antibiotics starts with the earliest stage of drug development. Read More Access to antibiotics Lack of access to novel antibiotics is a global problem that acutely affects whole countries and regions as well as certain population groups like children. Read More Scientific affairsREVIVE With the abandonment of antimicrobial research and development by many companies and academic laboratories, there is a risk of losing the hard-earned knowledge and experience of people who have worked in the field for decades. Read More Raising our voices to protect the #PowerOfAntibiotics 16.05.2023 A doctor-turned-patient’s perspective on cancer care and antimicrobial resistance 14.06.2023 Driving access to antibiotics in Malaysia 08.11.2023 The economic impact of AMR 16.05.2023 Overcoming a life-threatening infection in childbirth 18.11.2022 Overcoming neonatal sepsis in Uganda 16.05.2023 Building trust, treating infections in rural North India 16.05.2023 Treating newborns with sepsis in Uganda 16.05.2023 Treating patients with the right antibiotic in northeast India 08.11.2023 Students Against Superbugs – Champions in the fight against AMR View all media coverage Donate × Subscription Form 2 Sign up for GARDP newsletter Receive updates on GARDP’s efforts to transform lives and counter antibiotic resistance around the world. Personal Information - Select salutation - Mrs Mr Mx Dr Prof E-Mail First Name Last Name Your organization/company Desired content: - Desired content - General Communications Scientific AffairsREVIVE By ticking the box you confirm you agree to hearing from GARDP. We will use the information you provide with this form to email you updates on our work. You can change your mind at any time by clicking the unsubscribe link in the footer of any email newsletter you receive from us, or by contacting us at contact@gardp.org . We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking Subscribe below, you agree that we may process your information in accordance with these terms. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn about Mailchimp legal policies Subscribe to newsletter 1,013,388 lives already lost in 2024 Antimicrobial resistance is one of the world’s biggest killers. One person dies every 6 seconds. 000 days until the United Nations General Assembly High-Level Meeting on AMR Take action About About GARDP About antibiotics Our work Latest news Annual report Global network GARDP North America DNDi-GARDP Southern Africa 日本語資料 The Power Of Antibiotics campaign | GARDP Contribute Contact us Donate Requests for proposals Share your story Work with us Stay connected with us Subscribe © 2024 GARDP FOUNDATION, all rights reserved. Terms of use , Privacy notice , Cookies Notification Your are leaving GARDP US to transition to the GARDP Global Website Let’s go!...